drugset / Trial / NCT02999191
Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective of this trial is to investigate the relative bioavailability of BI 1467335, given as film-coated tablet compared to BI 1467335, given as oral solution. This assessment will be performed under fasted conditions. Furthermore, the effect of food on relative bioavailability of the tablet formulation of BI 1467335 will be investigated.
Timeline
- Start
- 2017-01-10
- Primary completion
- 2017-03-15
- Completion
- 2017-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1467335 | Unknown | — | Oral |
Indications
No indication recorded.